Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

José Moltó

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Journal of HIV Therapy|February 26, 2005
Therapeutic drug monitoring of antiretroviral agents scenarioJosé Moltó, Bonaventura Clotet
Enfermedades Infecciosas Y Microbiologia Clinica|July 3, 2009
[Lopinavir/ritonavir monotherapy as a simplification strategy in antiretroviral therapy in clinical practice]José Moltó, Bonaventura Clotet
Enfermedades Infecciosas Y Microbiologia Clinica|February 7, 2009
[Pharmacological interactions with darunavir]José Moltó, Marta Valle, Bonaventura Clotet
AIDS Reviews|June 3, 2015
Rezolsta® (Darunavir/Cobicistat): First Boosted Protease Inhibitor Co-formulated with CobicistatAdrián Curran, Ignacio Pérez-Valero, José Moltó
Translational Lung Cancer Research|January 23, 2016
Lung cancer in HIV-infected patients in the combination antiretroviral treatment eraJosé Moltó, Teresa Moran, Guillem Sirera, et al.
Cancers|September 10, 2021
Hodgkin Lymphoma in People Living with HIVJose-Tomas Navarro, José Moltó, Gustavo Tapia, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2012
Effect of milk thistle on the pharmacokinetics of darunavir-ritonavir in HIV-infected patientsJosé Moltó, Marta Valle, Cristina Miranda, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Herb-drug interaction between Echinacea purpurea and etravirine in HIV-infected patientsJosé Moltó, Marta Valle, Cristina Miranda, et al.
Cancers|June 28, 2023
Diffuse Large B-Cell Lymphoma in the HIV SettingMaria Huguet, José-Tomás Navarro, José Moltó, et al.
British Journal of Clinical Pharmacology|July 23, 2016
Population pharmacokinetic modelling of the changes in atazanavir plasma clearance caused by ritonavir plasma concentrations in HIV-1 infected patientsJosé Moltó, Javier A Estévez, Cristina Miranda, et al.
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Journal of HIV Therapy|February 26, 2005
Therapeutic drug monitoring of antiretroviral agents scenarioJosé Moltó, Bonaventura Clotet
Enfermedades Infecciosas Y Microbiologia Clinica|July 3, 2009
[Lopinavir/ritonavir monotherapy as a simplification strategy in antiretroviral therapy in clinical practice]José Moltó, Bonaventura Clotet
Enfermedades Infecciosas Y Microbiologia Clinica|February 7, 2009
[Pharmacological interactions with darunavir]José Moltó, Marta Valle, Bonaventura Clotet
AIDS Reviews|June 3, 2015
Rezolsta® (Darunavir/Cobicistat): First Boosted Protease Inhibitor Co-formulated with CobicistatAdrián Curran, Ignacio Pérez-Valero, José Moltó
Translational Lung Cancer Research|January 23, 2016
Lung cancer in HIV-infected patients in the combination antiretroviral treatment eraJosé Moltó, Teresa Moran, Guillem Sirera, et al.
Cancers|September 10, 2021
Hodgkin Lymphoma in People Living with HIVJose-Tomas Navarro, José Moltó, Gustavo Tapia, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2012
Effect of milk thistle on the pharmacokinetics of darunavir-ritonavir in HIV-infected patientsJosé Moltó, Marta Valle, Cristina Miranda, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Herb-drug interaction between Echinacea purpurea and etravirine in HIV-infected patientsJosé Moltó, Marta Valle, Cristina Miranda, et al.
Cancers|June 28, 2023
Diffuse Large B-Cell Lymphoma in the HIV SettingMaria Huguet, José-Tomás Navarro, José Moltó, et al.
British Journal of Clinical Pharmacology|July 23, 2016
Population pharmacokinetic modelling of the changes in atazanavir plasma clearance caused by ritonavir plasma concentrations in HIV-1 infected patientsJosé Moltó, Javier A Estévez, Cristina Miranda, et al.
Pageof 12